Reuters logo
BRIEF-Medigene completes recruitment for Phase I/II DC vaccine trial in AML
November 27, 2017 / 6:31 AM / in 14 days

BRIEF-Medigene completes recruitment for Phase I/II DC vaccine trial in AML

Nov 27 (Reuters) - Medigene AG:

* PTA-NEWS: MEDIGENE AG: PATIENT RECRUITMENT COMPLETED FOR PHASE I/II DC VACCINE TRIAL IN AML

* ‍COMPLETION OF STUDY, AS PREVIOUSLY ANNOUNCED, IS EXPECTED IN 2019 AFTER A TREATMENT PERIOD OF TWO YEARS FOR ALL PATIENTS​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below